IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Translational Data from OVATION 2 Trial Presented at AACR Special ...

Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.

Nigeria’s battle against HIV is faltering as critical diagnostic tests, including resistance testing, CD4 counts, hemoglobin ...

Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key ...

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

TORONTO -- A three-drug combination involving the B-cell maturation antigen (BCMA)-CD3 bispecific antibody elranatamab ...

Researchers evaluated the prevalence of low-level viremia and its influence on the risk for virologic failure in patients with HIV on antiretroviral therapy.

Claims that HIV has been permanently eradicated from people living with the virus are false. More research, refined delivery ...

People with new-onset type 1 diabetes can achieve similar improvements in C-peptide levels with a 0.5 mg/kg antithymocyte ...

Type 1 diabetes remains a persistent health-care burden despite substantial advances in care. Its preclinical disease course ...

GW Cancer Center to initiate Phase II trial evaluating neoadjuvant efti as monotherapy and in combination with chemotherapy prior to surgery in ...

New therapeutic targets for chronic intestinal inflammationThe research group led by Drs. Mitsuru Arase, Mari Murakami, and ...